TY  - GEN
AU  - Uckun,Fatih M
AU  - Vassilev,Alexei
AU  - Bartell,Steve
AU  - Zheng,Yaguo
AU  - Mahajan,Sandeep
AU  - Tibbles,Heather E
TI  - The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism
SN  - 1042-8194
PY  - 2004///0323
KW  - Adenosine Diphosphate
KW  - pharmacology
KW  - Agammaglobulinaemia Tyrosine Kinase
KW  - Amides
KW  - Animals
KW  - Aspirin
KW  - Bleeding Time
KW  - Catalytic Domain
KW  - drug effects
KW  - Collagen
KW  - antagonists & inhibitors
KW  - Drug Design
KW  - Drug Evaluation, Preclinical
KW  - Enzyme Inhibitors
KW  - Fibrinolytic Agents
KW  - Humans
KW  - Janus Kinase 3
KW  - Male
KW  - Mice
KW  - Mice, Inbred ICR
KW  - Nitriles
KW  - Peptide Fragments
KW  - Platelet Activation
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Membrane Glycoproteins
KW  - Protein-Tyrosine Kinases
KW  - Pulmonary Embolism
KW  - chemically induced
KW  - Quinazolines
KW  - Receptors, Collagen
KW  - Signal Transduction
KW  - Thrombin
KW  - Thromboembolism
KW  - Thromboplastin
KW  - toxicity
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.3109/10428190309178781
ER  -